MCDERMOTT WILL & EMERY

Comment: The recommended healthcare practice built up around respected lawyer Rau enjoys an excellent reputation across Germany for its industry-specific transactions experience. Pharma companies and financial investors often call on the industry experts at McDermott in transactions where other major firms are handling the corporate elements: this goes to show just how much clients appreciate the team’s regulatory expertise. Following Wodarz’s move from the firm in the previous year, which was much-noticed in the market, McDermott now also has a partner among its ranks who unites transaction experience and social law competence. Advice to medical product companies is also growing to become another of the practice’s focal points.
Strengths: Transactions.
Recommended: Dr. Stephan Rau (“efficient, pleasant collaboration”, competitor), Dr. Katharina Wodarz.
Practice: Strong focus on ?M&A, esp. in the hospital sector. Increasingly regulatory and contract law advice, often to medical product manufacturers. Also social and reimbursement law, compliance. Pharma advertising to a lesser extent. Clients: mainly hospital funding bodies, dialysis providers, medical product manufacturers and financial investors. Also biotech companies and the pharmaceuticals industry. (2 partners, 2 counsel, 1 associate)
Clients: ?? Regulatory advice to Apax Capital Partners on acquisition of Neuraxpharm; Apax Ponds on sale of Unilabs; Sanford on cooperation program with German hospitals related to stem cell therapy; expert opinion to Alloheim/Carlyle on admissibility of repackaging medication in blister packs free of charge in connection with a contract for pharmacies to supply care homes with pharmaceuticals; CompuGroup Medical on medical product law and public procurement.
  • Teilen